These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
246 related items for PubMed ID: 12870
1. Stable mutants of mammalian cells that overproduce the first three enzymes of pyrimidine nucleotide biosynthesis. Kempe TD, Swyryd EA, Bruist M, Stark GR. Cell; 1976 Dec; 9(4 Pt 1):541-50. PubMed ID: 12870 [Abstract] [Full Text] [Related]
2. Overproduction of the first three enzymes of pyrimidine nucleotide biosynthesis in Drosophila cells resistant to N-phosphonacetyl-L-aspartate. Laval M, Azou Y, Giorgi D, Rosset R. Exp Cell Res; 1986 Apr; 163(2):381-95. PubMed ID: 2869965 [Abstract] [Full Text] [Related]
3. Properties of single-step mutants of Syrian hamster cell lines resistant to N-(phosphonacetyl)-L-aspartate. Zieg J, Clayton CE, Ardeshir F, Giulotto E, Swyryd EA, Stark GR. Mol Cell Biol; 1983 Nov; 3(11):2089-98. PubMed ID: 6656764 [Abstract] [Full Text] [Related]
4. Mechanism of resistance of variants of the Lewis lung carcinoma to N-(phosphonacetyl)-L-aspartic acid. Kensler TW, Mutter G, Hankerson JG, Reck LJ, Harley C, Han N, Ardalan B, Cysyk RL, Johnson RK, Jayaram HN, Cooney DA. Cancer Res; 1981 Mar; 41(3):894-904. PubMed ID: 7459875 [Abstract] [Full Text] [Related]
5. Coordinate synthesis of the enzymes of pyrimidine biosynthesis in Bacillus subtilis. Paulus TJ, McGarry TJ, Shekelle PG, Rosenzweig S, Switzer RL. J Bacteriol; 1982 Feb; 149(2):775-8. PubMed ID: 6120161 [Abstract] [Full Text] [Related]
6. The overall synthesis of L-5,6-dihydroorotate by multienzymatic protein pyr1-3 from hamster cells. Kinetic studies, substrate channeling, and the effects of inhibitors. Christopherson RI, Jones ME. J Biol Chem; 1980 Dec 10; 255(23):11381-95. PubMed ID: 6108323 [Abstract] [Full Text] [Related]
7. Uracil nucleotide synthesis in a human breast cancer cell line (MCF-7) and in two drug-resistant sublines that contain increased levels of enzymes of the de novo pyrimidine pathway. Karle JM, Cowan KH, Chisena CA, Cysyk RL. Mol Pharmacol; 1986 Aug 10; 30(2):136-41. PubMed ID: 2874477 [Abstract] [Full Text] [Related]
8. Chemotherapeutic inhibitors of the enzymes of the de novo pyrimidine pathway. Kensler TW, Cooney DA. Adv Pharmacol Chemother; 1981 Aug 10; 18():273-352. PubMed ID: 6119898 [No Abstract] [Full Text] [Related]
9. Antipyrimidine effects of five different pyrimidine de novo synthesis inhibitors in three head and neck cancer cell lines. Peters GJ. Nucleosides Nucleotides Nucleic Acids; 2018 Aug 10; 37(6):329-339. PubMed ID: 29723133 [Abstract] [Full Text] [Related]
12. Enzymes of de novo pyrimidine biosynthesis in Babesia rodhaini. Holland JW, Gero AM, O'Sullivan WJ. J Protozool; 1983 Feb 10; 30(1):36-40. PubMed ID: 6134826 [Abstract] [Full Text] [Related]
13. Effects of acivicin and PALA, singly and in combination, on de novo pyrimidine biosynthesis. Kensler TW, Jayaram HN, Cooney DA. Adv Enzyme Regul; 1982 Feb 10; 20():57-73. PubMed ID: 7113804 [Abstract] [Full Text] [Related]
19. Multiple mechanisms of N-phosphonacetyl-L-aspartate resistance in human cell lines: carbamyl-P synthetase/aspartate transcarbamylase/dihydro-orotase gene amplification is frequent only when chromosome 2 is rearranged. Smith KA, Chernova OB, Groves RP, Stark MB, Martínez JL, Davidson JN, Trent JM, Patterson TE, Agarwal A, Duncan P, Agarwal ML, Stark GR. Proc Natl Acad Sci U S A; 1997 Mar 04; 94(5):1816-21. PubMed ID: 9050862 [Abstract] [Full Text] [Related]
20. Selection of N-(phosphonacetyl)-L-aspartate resistant Chinese hamster mutants in the presence of the uridine uptake inhibitor dipyridamole. Tessera L, Mucciolo E, Bertoni L, Giulotto E. Anticancer Res; 1995 Mar 04; 15(1):189-92. PubMed ID: 7733632 [Abstract] [Full Text] [Related] Page: [Next] [New Search]